AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100

Alzinova AB reports positive final Phase 1b results for ALZ-101 in Alzheimer's

Primrose Bio launches Prima RNApols ExTend RNA polymerase for long-template mRNA manufacturing

Merck's CAPVAXIVE approved by EC for pneumococcal disease prevention

Sanofi secures FDA fast track designation for chlamydia vaccine candidate

Anixa Biosciences secures US patent allowance for ovarian cancer vaccine

Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion

Everest Medicines' EVM14 IND application receives US FDA approval

Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval

Centivax partners with Emery Pharma on universal flu vaccine

Avance Biosciences registers with CLIA program

GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine

hVIVO secures GBP2m contract for final stage of hMPV characterisation study

EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine

Sanofi and J&J discontinue phase 3 study of E. coli vaccine candidate